Baseline circulating thrombospondin-2 (TSP2) level was identified as a potential novel hepatic fibrosis biomarker that associates with development and progression of hepatic fibrosis in patients with nonalcoholic fatty liver disease and type 2 diabetes. Here, we investigated whether circulating TSP2 levels changed with improvement in liver stiffness (LS), which reflects liver fibrosis on transient elastography.

中文翻译：

---

2型糖尿病患者血清血小板反应蛋白-2水平随肝硬度改善的变化

基线循环血小板反应蛋白-2 (TSP2) 水平被确定为一种潜在的新型肝纤维化生物标志物，与非酒精性脂肪肝病和 2 型糖尿病患者肝纤维化的发生和进展相关。在这里，我们研究了循环 TSP2 水平是否随着肝脏硬度 (LS) 的改善而变化，肝脏硬度 (LS) 反映了瞬时弹性成像上的肝纤维化。